2019
$221M
from 13 investors over 13 rounds
ArsenalBio raised $221M on September 6, 2022
Investors: Parker Institute for Cancer Immunotherapy, Kleiner Perkins, SoftBank Investment Advisers, Hitachi Ventures, UCSF, Sixth Street and Westlake Village BioPartners®
ArsenalBio raised $85M on October 17, 2019
Investors: UCSF Foundation Investment Company, Parker Institute for Cancer Immunotherapy, Westlake Village BioPartners®, Osage University Partners (OUP), University of California and Kleiner Perkins